The AFB Drug Susceptibility Oral Bedaquiline Panel (8 Drugs) helps determine Mycobacterium tuberculosis resistance to Bedaquiline and other essential second-line oral medications. Metropolis Healthcare performs this panel on pure culture isolates to ensure highly accurate, clinically useful results. It is particularly valuable for managing MDR, pre-XDR, and XDR TB cases
Price:
Rs. 8,480.00
Sample Type: (Mtb Complex) Bottle , LJ slant , MGIT Tube
Fasting Not Requierd
Frequently Asked Questions (FAQ's):
What does the AFB Oral Bedaquiline Panel at Metropolis Healthcare include?
It tests susceptibility to eight key second-line oral anti-TB drugs, including Bedaquiline, to assess resistance patterns.
How does Metropolis Healthcare perform this susceptibility test?
The analysis is conducted on pure TB cultures using validated culture-based DST methods and stringent biosafety standards.
Who should take this Bedaquiline drug panel at Metropolis Healthcare?
Patients with MDR TB, suspected pre-XDR/XDR TB, relapse, or treatment failure benefit most from this comprehensive DST.
Why is Bedaquiline resistance testing important?
It ensures the effectiveness of one of the most crucial second-line drugs used for resistant TB treatment.
Why must the test be performed on a pure culture?
Pure isolates prevent contamination and mixed-strain interference, ensuring precise resistance profiling.
How do the results help physicians?
They support personalised therapy by indicating which second-line drugs will remain effective in the patient’s regimen.
Is any preparation required before providing the sample?
No preparation is needed; a verified pure culture isolate must be submitted by the referring laboratory.
How long do results from Metropolis Healthcare take?
Because this is a culture-based test, results generally take several weeks, depending on growth characteristics.